Key Points
Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023..
Mounjaro than those taking Novo Nordisk's (NOVOb.CO) popular rival weight loss drug, according to an analysis of health records and other data...
Within one year of starting treatment, 42.3% of those taking tirzepatide - the active ingredient in Mounjaro and Zepbound - had lost at least 15% of their weight, compared with 19.3% among patients taking semaglutide - the main ingredient in Wegovy and Ozempic, the study published on medRxiv in advance of peer review found...
In the absence of head-to-head randomized controlled trials comparing the two drugs, researchers used electronic health records and pharmacy dispensing data to analyze weight loss trajectories in 9,193 patients receiving Mounjaro and the same number of closely matched patients receiving Ozempic..
The researchers note that Ozempic and Mounjaro are both intended for use by people with type 2 diabetes, but half of the study participants were using the drugs for weight loss only, which may have impacted the results...
You might be interested in
Mounjaro for weight loss: Trial participants lost 15% of bodyweight
24, Jun, 23A new study suggests Mounjaro is a stronger and more potent drug for weight loss than Ozempic — overweight patients dramatically trimmed waistlines.
Stars who have taken weight loss drugs like Ozempic, Wegovy
16, Mar, 23Jimmy Kimmel said: "When I look around this room, I can't help but wonder 'Is Ozempic right for me?'" while presenting the 2023 Oscars.
Weight loss drugs making waves: All about Ozempic, Wegovy, and Mounjaro
18, Jul, 23Doctors in India are prescribing semaglutide, available under various brands like Ozempic, Wegovy, and Mounjaro pens, along with other pill forms readily accessible at local chemists, with a valid prescription.
Belgium seizes fake weight-loss drugs containing insulin
30, Oct, 23Belgium’s drug regulator said it had seized counterfeit versions of semaglutide, the active ingredient in Novo Nordisk's (NOVOb.CO) popular obesity drug Wegovy, in which the injector pens contained insulin.